Bioventix

The Company is a biotechnology company specializing in the development of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics focusing on the areas of clinical diagnostics and drugs of abuse testing. The Company uses its technology in the fields of clinical diagnostics. Its develops products for Thyroid, Fertility, Oncology, Vitamin D, Drugs of Abuse and other diseases. Its product, Vitamin D SMA is a steroid hormone involved in the intestinal absorption of calcium and the regulation of calcium homeostasis but it has also evolved into a hormone that has a diversity of biologic effects.
Type
Public
HQ
Farnham, GB
Employees
13 (est)

Bioventix Locations

Farnham, GB

Bioventix Metrics

Bioventix Summary

Market capitalization

£69.4 M

Closing share price

£13.8

Bioventix Market Value History

Bioventix Company Life

You may also be interested in